Actualités Avalo Therapeutics Inc - AVTX | Actions NASDAQ | ADVFN

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Avalo Therapeutics Inc (AVTX)
Avalo Therapeutics Inc (AVTX) Actualités

Avalo Therapeutics Inc (AVTX)

7,43

-0,37

(-4,74%)

Fermé 02 Janvier 10:00PM

Retardé de 15 minutes

7,46

0,03

(0,40%)

Après les heures de négociation: 1:59AM

Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Form 8-K - Current report

Form 8-K - Current report

Avalo Announces Participation in September Investor Conferences

WAYNE, Pa. and ROCKVILLE, Md., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates

Expects to enroll first patient in Phase 2 LOTUS Trial of AVTX-009 in hidradenitis suppurativa in the second...

1
2
Suivant

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Avalo Therapeutics

OMXS30 Double Short

Manulife Multifactor US ...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales